For the Record provides postings of appointment, committee, grant, award, and other notices set out by collective agreements and university policies and processes. It is the university’s primary vehicle for sharing this information with our community.

Submit For the Record information for posting to Gazette editor Andrew Carroll.

Headship Search Committee, Department of Urology

Dr. Robert Siemens’ second term as Head of the Department of Urology will end on June 30, 2022, and a Search Committee is to be established to make a recommendation to the board chairs of the participating hospitals and the provost of Queen’s University on its future leadership. The Search Committee, which is being established in accordance with the Senate document governing the Appointment of Clinical/Academic Department Heads is to be comprised of:

• the Chief of Staff (or delegate) of each participating Hospital
• one representative of each participating Hospital selected by its Board
• one member selected by the Department of Urology
• one Head of a Clinical Department, selected by the Chiefs of Staff of the participating Hospitals and the Dean
• the Dean of the Faculty (or Vice-Dean)
• Two members of the faculty, one of whom shall be from the Department of Urology, appointed by the Dean
• two learners, one of whom shall be enrolled in a graduate, or post-graduate medical program, to be selected by the respective groups.

Following approval of the composition of the committee, the membership will be announced in the Queen's Gazette and the appropriate Hospital circulars.

At this time, nominations to the Headship Search Committee are invited. Additionally, faculty, staff, students, residents and all other members of the hospital and university communities, are invited to submit their comments, in writing, on the present state and future prospects of the Department of Urology, as well as the names of possible candidates for the headship and the reasons for supporting each nominee.

Written submissions are to be directed to the co-chairs c/o Crystal Tripple, Staffing Officer, at ct82@queensu.ca. Responses received will remain confidential and will be shared only with the members of the review committee; anonymous submissions will not be considered.

Headship Search Committee, Department of Ophthalmology

Dr. Martin ten Hove’s second term as Head of the Department of Ophthalmology will end on June 30, 2022, and a Search Committee is to be established to make a recommendation to the board chairs of the participating hospitals and the provost of Queen’s University on its future leadership. The Search Committee, which is being established in accordance with the Senate document governing the Appointment of Clinical/Academic Department Heads is to be comprised of:

• the Chief of Staff (or delegate) of each participating Hospital
• one representative of each participating Hospital selected by its Board
• one member selected by the Department of Ophthalmology
• one Head of a Clinical Department, selected by the Chiefs of Staff of the participating Hospitals and the Dean
• the Dean of the Faculty (or Vice-Dean)
• Two members of the faculty, one of whom shall be from the Department of Ophthalmology, appointed by the Dean
• two learners, one of whom shall be enrolled in a graduate, or post-graduate medical program, to be selected by the respective groups.

Following approval of the composition of the committee, the membership will be announced in the Queen's Gazette and the appropriate Hospital circulars.

At this time, nominations to the Headship Search Committee are invited. Additionally, faculty, staff, students, residents and all other members of the hospital and university communities, are invited to submit their comments, in writing, on the present state and future prospects of the Department of Ophthalmology, as well as the names of possible candidates for the headship and the reasons for supporting each nominee.

Written submissions are to be directed to the co-chairs c/o Crystal Tripple, Staffing Officer, at ct82@queensu.ca. Responses received will remain confidential and will be shared only with the members of the review committee; anonymous submissions will not be considered.